In case this product is given to induce ovulation concomitantly with or subsequently to the ovarian stimulating hormone, excessive ovarian reaction such as Meigs syndrome accompanied by ovarian enlargement, rupture of the enlarged ovary, ascites, and hydrothorax may occur. Furthermore, thrombosis and cerebral infarction may occur due to hemoconcentration and hypercoagulation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
